journal article·2026-08

Cell-free fat extract attenuates temporomandibular joint osteoarthritis via repressing ATF3-binding chromatin accessibility

Dahe Zhang, Bijun Kang, Shaonan Wan, Xiaohan Liu, Simo Xia, Yuxin Zhang, Wenjie Zhang, Pei Shen, Chi Yang

Biomaterials· Volume 331
Publisher page

Abstract

Temporomandibular joint osteoarthritis (TMJOA) is a degenerative disease characterized by cartilage degradation and synovial inflammation with limited therapeutic options. In our study, cell-free fat extract (CEFFE), a bioactive fraction derived from adipose tissue, is evaluated as a therapeutic strategy for TMJOA. In chondrocytes, CEFFE enhances proliferation and viability, attenuates inflammatory apoptosis, and preserves extracellular matrix homeostasis by upregulating Col2a1 and Sox9 while suppressing matrix metalloproteinases. Integrated transcriptomic and epigenomic analyses demonstrate that CEFFE reduces the activating transcription factor 3 (ATF3) binding at the promoter of actin binding LIM protein 1 (ABLIM1) via repressing ATF3-binding chromatin accessibility, thereby inhibiting nuclear factor kappa-B (NF-κB) signaling. In a rat model of TMJOA, intra-articular administration of CEFFE alleviates cartilage degeneration, subchondral bone loss, and synovitis, without systemic toxicity. CEFFE also suppresses pro-inflammatory M1 macrophage polarization and decreases interleukin-1β and tumor necrosis factor-α expression in synovial tissue. These findings identify CEFFE as a dual-target therapeutic agent that modulates both chondrocytes and macrophages through epigenetic regulation of ATF3/ABLIM1/NF-κB signaling. Our study highlights CEFFE as a safe and accessible biomaterial with potential for clinical translation as a regenerative and anti-inflammatory strategy for TMJOA.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Temporomandibular Joint Disorders · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (84)

Show source-provided references
1. Pathological mechanism of chondrocytes and the surrounding environment during osteoarthritis of temporomandibular joint10.1111/jcmm.16514 ↗
2. Anatomy of the mandible, temporomandibular joint, and dentition10.1016/j.nic.2022.07.009 ↗
3. Temporomandibular joint osteoarthritis: pathogenic mechanisms involving the cartilage and subchondral bone, and potential therapeutic strategies for joint regeneration10.3390/ijms24010171 ↗
4. Macrophage polarization in the osteoarthritis pathogenesis and treatment10.1111/os.14302 ↗
5. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis10.1038/nrrheum.2010.196 ↗
6. Effect of mechanical loading on the metabolic activity of cells in the temporomandibular joint: a systematic review10.1007/s00784-017-2189-9 ↗
7. Osteoarthritis: toward a comprehensive understanding of pathological mechanism10.1038/boneres.2016.44 ↗
8. Will unilateral temporomandibular joint anterior disc displacement in teenagers lead to asymmetry of condyle and mandible? A longitudinal study10.1016/j.jcms.2016.01.019 ↗
9. Acquired abnormalities of the temporomandibular joint10.1016/j.coms.2017.08.005 ↗
10. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis10.1016/j.biomaterials.2019.02.006 ↗
11. Temporomandibular joint disc displacement with reduction: a review of mechanisms and clinical presentation10.1590/1678-7757-2018-0433 ↗
12. TMJ disc displacement without reduction management: a systematic review10.1177/0022034514528333 ↗
13. Intra-articular treatment of temporomandibular joint osteoarthritis by injecting actively-loaded meloxicam liposomes with dual-functions of anti-inflammation and lubrication
14. A new frontier in temporomandibular joint osteoarthritis treatment: exosome-based therapeutic strategy10.3389/fbioe.2022.1074536 ↗
15. [Research progress in mesenchymal stem cell-related therapies in the treatment of temporomandibular joint osteoarthritis]
16. Shattering barriers toward clinically meaningful MSC therapies10.1126/sciadv.aba6884 ↗
17. Preliminary study of standard artificial temporomandibular joint replacement with preservation of muscle attachment10.1016/j.joms.2020.12.012 ↗
18. Effect of arthroscopic discopexy on condylar growth in adolescents with temporomandibular joint disc displacement without reduction: a retrospective self-controlled case series study10.1016/j.jcms.2023.06.009 ↗
19. Efficacy of Arthroscopic Diskopexy on condylar growth in temporomandibular joint anterior disk displacement: a randomized clinical trial10.1097/PRS.0000000000010966 ↗
20. Influence of local factors on the condylar growth after arthroscopic discopexy in adolescents with temporomandibular joint anterior disc displacement without reduction: a retrospective longitudinal study10.1016/j.ijom.2023.10.005 ↗
21. Temporomandibular joint ankylosis can be successfully treated with TMJ concepts patient-fitted total joint prosthesis and autogenous fat grafts10.1016/j.joms.2016.01.017 ↗
22. The fate of autogenous free fat grafts in the human temporomandibular joint using magnetic resonance imaging10.1016/j.jcms.2015.08.024 ↗
23. Autologous fat grafting: the science behind the surgery10.1093/asj/sjw004 ↗
24. Fat extract improves random pattern skin flap survival in a rat model10.1093/asj/sjz112 ↗
25. Cell-free fat extract promotes tissue regeneration in a tissue expansion model10.1186/s13287-020-1564-7 ↗
26. Fat extract improves fat graft survival via proangiogenic, anti-apoptotic and pro-proliferative activities10.1186/s13287-019-1290-1 ↗
27. MicroRNA-29b promotes subchondral bone loss in TMJ osteoarthritis10.1177/0022034520937617 ↗
28. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues10.1038/nmeth.4396 ↗
29. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility10.5483/BMBRep.2018.51.7.106 ↗
30. Exploration and biological evaluation of 7-methoxy-3-methyl-1H-chromeno[4,3-c]pyrazol-4-one as an activating transcription factor 3 inducer for managing metabolic syndrome10.1016/j.ejmech.2022.114951 ↗
31. Large language model-assisted genotoxic metal-phenolic nanoplatform for Osteosarcoma therapy10.1002/smll.202403044 ↗
32. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy10.1186/s13287-018-1014-y ↗
33. Insights on molecular mechanisms of chondrocytes death in osteoarthritis10.3390/ijms17122146 ↗
34. A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development10.1038/s41467-019-09839-x ↗
35. The ECM-cell interaction of cartilage extracellular matrix on chondrocytes10.1155/2014/648459 ↗
36. Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation10.3389/fphys.2021.663978 ↗
37. Selective MMP-13 inhibitors: promising agents for the therapy of osteoarthritis10.2174/0929867326666181217153118 ↗
38. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position10.1038/nmeth.2688 ↗
39. Integrative single-cell analysis reveals transcriptional and epigenetic regulatory features of human developmental dysplasia of the hip10.1016/j.joca.2025.02.788 ↗
40. Chromatin accessibility landscape of articular knee cartilage reveals aberrant enhancer regulation in osteoarthritis
41. H3K9me3 loss and ERVs activation as hallmarks for osteoarthritis progression and knee joint aging10.1016/j.joca.2024.08.004 ↗
42. Identification of anterior cruciate ligament fibroblasts and their contribution to knee osteoarthritis progression using single-cell analyses
43. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis10.1186/s12915-021-01011-6 ↗
44. ATF3 gene. Genomic organization, promoter, and regulation10.1074/jbc.271.3.1695 ↗
45. ATF3 transcription factor and its emerging roles in immunity and cancer10.1007/s00109-009-0520-x ↗
46. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component?10.3727/105221610X12819686555015 ↗
47. ATF3 deficiency in chondrocytes alleviates osteoarthritis development10.1002/path.4739 ↗
48. Exploring the role of ATF3 and ferroptosis-related RNA expression in osteoarthritis: an RNA analysis approach to immune infiltration
49. Identification of key hub genes in knee osteoarthritis through integrated bioinformatics analysis
50. Atf3 + senescent chondrocytes mediate meniscus degeneration in aging10.1186/s13075-025-03566-z ↗
51. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation10.1016/j.pain.2006.12.022 ↗
52. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis10.1097/j.pain.0000000000000132 ↗
53. ATF3 as a potential diagnostic marker of early-stage osteoarthritis and its correlation with immune infiltration through bioinformatics analysis10.1302/2046-3758.119.BJR-2022-0075.R1 ↗
54. Periodic mechanical stress inhibits the development of osteoarthritis via regulating ATF3-Akt axis10.2147/JIR.S419186 ↗
55. Cytokine-induced MMP13 expression in human chondrocytes is dependent on activating transcription factor 3 (ATF3) regulation10.1074/jbc.M116.756601 ↗
56. Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular Carcinoma10.7150/ijbs.46285 ↗
57. abLIM1 constructs non-erythroid cortical actin networks to prevent mechanical tension-induced blebbing10.1038/s41421-018-0040-3 ↗
58. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling10.1038/s41418-024-01256-y ↗
59. Osteoarthritis: pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
60. Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes
61. Endogenous regulation of the acute inflammatory response10.1023/A:1015944709177 ↗
62. Zinc finger-inspired peptide-metal-phenolic nanointerface enhances bone-implant integration under bacterial infection microenvironment through immune modulation and osteogenesis promotion
63. Interplay between key molecular signaling pathways and immune players following brain irradiation10.1155/mi/8833271 ↗
64. Insights on inflammatory pathways and their cross-talk: a comprehensive review on asthma10.1007/s11033-025-11007-y ↗
65. Therapeutic correlation of TLR-4 mediated NF-κB inflammatory pathways in ischemic injuries10.2174/0113894501322228240830063605 ↗
66. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology
67. Regulatory T cells engineered with polyphenol-functionalized immunosuppressant nanocomplexes for rebuilding periodontal hard tissue under inflammation-challenged microenvironment10.1016/j.biomaterials.2024.122961 ↗
68. Macrophages regulate the progression of osteoarthritis10.1016/j.joca.2020.01.007 ↗
69. Stem cell-directed therapies for osteoarthritis: the promise and the practice10.1002/stem.3139 ↗
70. PER2 interaction with HSP70 promotes cuproptosis in oral squamous carcinoma cells by decreasing AKT stability10.1038/s41419-025-07523-1 ↗
71. Synovitis score: discrimination between chronic low-grade and high-grade synovitis10.1111/j.1365-2559.2006.02508.x ↗
72. Orosomucoid 1 ameliorates temporomandibular joint osteoarthritis by maintaining cartilage homeostasis
73. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse10.1016/j.joca.2010.05.025 ↗
74. Improving RNA-seq expression estimates by correcting for fragment bias10.1186/gb-2011-12-3-r22 ↗
75. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features10.1093/bioinformatics/btt656 ↗
76. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq210.1186/s13059-014-0550-8 ↗
77. Team · 2021
78. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data
79. Fast and accurate short read alignment with Burrows-Wheeler transform10.1093/bioinformatics/btp324 ↗
80. Model-based analysis of ChIP-Seq (MACS)10.1186/gb-2008-9-9-r137 ↗
81. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization10.1093/bioinformatics/btv145 ↗
82. Young · 2012
83. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis10.1093/nar/gkab447 ↗
84. CUT&Tag for efficient epigenomic profiling of small samples and single cells10.1038/s41467-019-09982-5 ↗